eriodictyol has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, LH; Liu, JY; Yin, JB | 1 |
| Li, H; Peng, H; Shen, L; Wang, R | 1 |
2 other study(ies) available for eriodictyol and Colitis Gravis
| Article | Year |
|---|---|
Eriodictyol attenuates TNBS-induced ulcerative colitis through repressing TLR4/NF-kB signaling pathway in rats.
Topics: Animals; Colitis, Ulcerative; Flavanones; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Sulfonic Acids; Toll-Like Receptor 4 | 2021 |
Eriodictyol attenuates dextran sodium sulphate-induced colitis in mice by regulating the sonic hedgehog signalling pathway.
Topics: Animals; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Flavanones; Hedgehog Proteins; Inflammation; Male; Mice; Mice, Inbred C57BL; Models, Animal; Oxidative Stress; Signal Transduction; Veratrum Alkaloids | 2021 |